SCHEMBL3710979

SCHEMBL3710979

Oc1nc2nc(-c3ccccn3)nn2c(O)c1-c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.40
SMN1; SMN2 Q16637 5/20 0.40
NPC1 O15118 4/20 0.40
TP53 P04637 3/20 0.40
PKM P14618 2/20 0.40
DCTPP1 Q9H773 2/20 0.40
LMNA P02545 4/20 0.40
KDM4E B2RXH2 4/20 0.40
MAPT P10636 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
AKT1 P31749 2/20 0.39
AKT2 P31751 2/20 0.39
PDE10A Q9Y233 2/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
KLF5 Q13887 1/20 0.39
HSD17B10 Q99714 1/20 0.39
F2 P00734 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL364249 0.76 AKT1 (0.43) RAB9ASMN1; SMN2NPC1TP53PKM
SCHEMBL2964669 0.75 KDM4E (0.49) RAB9ASMN1; SMN2NPC1TP53LMNA
SCHEMBL10987043 0.72 KDM4E (0.44) RAB9ANPC1TP53LMNAKDM4E
SCHEMBL3702792 0.72 AKT1 (0.42) RAB9ASMN1; SMN2NPC1TP53PKM
SCHEMBL3702794 0.72 AKT1 (0.56) RAB9ASMN1; SMN2NPC1TP53PKM
SCHEMBL11035817 0.72 KDM4E (0.49) RAB9ASMN1; SMN2NPC1TP53LMNA
SCHEMBL2968050 0.71 ALDH1A1 (0.39) LMNAKDM4EMAPTPDE10AALDH1A1
SCHEMBL2970170 0.71 PTGS1 (0.36) RAB9ASMN1; SMN2NPC1TP53LMNA
SCHEMBL10982300 0.70 PDE10A (0.57) RAB9ASMN1; SMN2NPC1TP53LMNA
SCHEMBL868954 0.70 KDM4E (0.49) SMN1; SMN2PKMLMNAKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2396330-A1 FUSED PYRIMIDINES Bayer Pharma Aktiengesellschaft (DE) 2011-12-21 EP disclosed
WO-2010091808-A1 FUSED PYRIMIDINES BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-08-19 WO disclosed